Krilogy Financial LLC Buys 307 Shares of Cigna Co. (NYSE:CI)

Krilogy Financial LLC increased its stake in Cigna Co. (NYSE:CIGet Rating) by 10.9% during the second quarter, Holdings Channel reports. The firm owned 3,111 shares of the health services provider’s stock after acquiring an additional 307 shares during the period. Krilogy Financial LLC’s holdings in Cigna were worth $820,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Country Trust Bank grew its position in Cigna by 116.7% in the first quarter. Country Trust Bank now owns 104 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 56 shares during the last quarter. Pittenger & Anderson Inc. bought a new position in Cigna in the second quarter valued at about $26,000. Wagner Wealth Management LLC grew its position in Cigna by 144.4% in the fourth quarter. Wagner Wealth Management LLC now owns 132 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 78 shares during the last quarter. Exane Derivatives grew its position in Cigna by 6,200.0% in the first quarter. Exane Derivatives now owns 126 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 124 shares during the last quarter. Finally, Lloyd Advisory Services LLC. bought a new position in Cigna in the first quarter valued at about $30,000. Institutional investors own 89.54% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on CI. Royal Bank of Canada lifted their target price on Cigna from $272.00 to $294.00 in a research report on Friday, August 5th. SVB Leerink lifted their price target on Cigna from $276.00 to $305.00 and gave the company a “market perform” rating in a research note on Wednesday, August 10th. Credit Suisse Group lifted their price target on Cigna from $315.00 to $329.00 and gave the company an “outperform” rating in a research note on Monday, August 8th. Sanford C. Bernstein lifted their price target on Cigna from $258.00 to $301.00 and gave the company a “mkt perform” rating in a research note on Friday, May 27th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $271.00 price target (down from $330.00) on shares of Cigna in a research note on Thursday, July 14th. Seven equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $305.58.

Cigna Price Performance

Shares of Cigna stock opened at $282.90 on Friday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $86.32 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 1.11 and a beta of 0.71. The business’s 50-day moving average price is $283.36 and its 200-day moving average price is $265.05. Cigna Co. has a 12 month low of $191.74 and a 12 month high of $296.29.

Cigna (NYSE:CIGet Rating) last issued its earnings results on Thursday, August 4th. The health services provider reported $6.22 earnings per share for the quarter, beating the consensus estimate of $5.62 by $0.60. The company had revenue of $45.48 billion during the quarter, compared to analysts’ expectations of $44.34 billion. Cigna had a return on equity of 15.91% and a net margin of 3.05%. Cigna’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business posted $5.24 EPS. Sell-side analysts forecast that Cigna Co. will post 22.94 EPS for the current fiscal year.

Cigna Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 22nd. Investors of record on Wednesday, September 7th were issued a dividend of $1.12 per share. This represents a $4.48 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend was Tuesday, September 6th. Cigna’s dividend payout ratio is presently 26.71%.

Insider Activity at Cigna

In other Cigna news, insider Jason D. Sadler sold 3,458 shares of the stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $270.00, for a total value of $933,660.00. Following the completion of the sale, the insider now owns 31,749 shares in the company, valued at approximately $8,572,230. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Cigna news, CEO Eric P. Palmer sold 6,521 shares of the stock in a transaction that occurred on Thursday, July 7th. The stock was sold at an average price of $275.00, for a total value of $1,793,275.00. Following the completion of the sale, the chief executive officer now owns 39,978 shares in the company, valued at approximately $10,993,950. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jason D. Sadler sold 3,458 shares of the stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $270.00, for a total value of $933,660.00. Following the completion of the sale, the insider now owns 31,749 shares of the company’s stock, valued at approximately $8,572,230. The disclosure for this sale can be found here. Insiders sold 41,158 shares of company stock worth $11,581,956 in the last ninety days. 0.80% of the stock is owned by company insiders.

Cigna Profile

(Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Co. (NYSE:CIGet Rating).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.